The À344C/T polymorphism in the 5 0 promoter region of CYP11B2 has been associated with arterial hypertension and hypertension-related phenotypes with conflicting results, probably attributable to gender-, age-, and ethnicity-related variations in its phenotypic expression. We evaluated the association of À344C/T polymorphism with blood pressure and prevalence of hypertension in a large sample of men and women participating to the IMMIDIET project, a population-based cross-sectional study in three European countries (Italy, UK, Belgium). In this population sample, the C allele of À344C/T was associated with higher blood pressure and prevalence of hypertension in younger men but not in older men and in women, thus, suggesting that this allele may confer increased susceptibility to hypertension early in life.
The aldosterone synthase gene, CYP11B2, encodes for a cytochrome P450 enzyme, involved in the terminal steps of aldosterone synthesis in the zona glomerulosa cells of human adrenal glands. The candidacy for this gene is based on its pathogenic role in the syndrome of glucocorticoidremediable aldosteronism. 1 The À344C/T polymorphism, which is located at a putative binding site for the steroidogenic transcription factor (SF-1), has been associated with hypertension and with other hypertensive intermediate phenotypes related to aldosterone synthesis and activity. 2, 3 Although some studies have not confirmed these associations, 2 this locus may be important in blood pressure and cardiovascular regulation. 2, 3 Several factors such as gender, 4 ethnicity 5 and age 6-8 could be involved in the phenotypic expression of this polymorphism. In particular, Sarzani et al. 7 reported that C allele of À344C/T was associated with higher blood pressure levels in young adults.
We assessed the association between this genetic variant and blood pressure in 802 European male/ female couples, recruited in the framework of the IMMIDIET project (Dietary habit profile in European Communities with Different Risk of Myocardial Infarction: the Impact of Migration as a Model of Gene/Environment Interaction). 9 The IMMIDIET project is a population-based cross-sectional study designed to investigate gene-environment interaction in relation to cardiovascular risk in married healthy couples aged 30-60 years from Italy, Belgium and England. The couples were randomly recruited from general practice in southeast England (n ¼ 263), the Flemish territory of Belgium (n ¼ 268), and the Abruzzo region of Italy (n ¼ 271). The study was approved by the ethics committees of all participating institutions. All study participants agreed to give blood samples for DNA analysis and biochemical measurements, by written informed consent. Participating couples attended their general practitioner's clinic for the screening visit performed by trained physicians and nurses of the IMMIDIET staff.
Blood pressure was measured with an automatic device (OMRON-HEM-705CP; Omron Health Care Inc., Bannockburn, IL, USA) after the subject had been resting in the seated position for 10 min and before blood sampling. Systolic and diastolic blood pressures (SBP and DBP) were taken three times, with 2-min intervals between measurements and the average of the last two readings was used for the analyses. The body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in metres (kg/m 2 ). Hypertension was defined according to the WHO/ISH criteria. 10 The DNA samples were genotyped by polymerase chain reaction-restriction fragment length polymorphism for À344C/T variant of CYP11B2 according to Russo et al. 6 Data are presented as mean7s.d. All statistical analyses were performed separately on men and women. Two-tailed P-values o0.05 were considered statistically significant. Standard statistical genetic methods were used to verify that the assumption of Hardy-Weinberg equilibrium was appropriate. Differences in allele frequency were determined by w 2 statistics. The association between À344C/T genotypes and prevalence of hypertension was first assessed by w 2 statistics and then compared by logistic regression analysis adjusting for covariates (age, national origin, BMI and menopausal status). Odds ratios and their 95% confidence intervals (CI) were also calculated. Statistical analyses were performed with the SPSS statistical software package (SPSS 11.0, Chicago, IL, USA).
The À344C/T polymorphism was genotyped in a total of 1604 individuals. The genotyping success rate was 96%. A 10% random sample was genotyped twice in a blinded manner without any discrepancies between genotype score. The distribution of genotypes was in Hardy-Weinberg equilibrium. The frequency of the C/T alleles in the entire population was 45/55% in men and 46/54% in women (men: CC 159; CT 376; TT 231; women: CC 142; CT 402; TT 220). There was no statistically significant difference in allelic distribution between men and women and among populations (Italy: In untreated participants (n ¼ 1392), C allele was significantly associated with higher blood pressure in men (CC þ CT vs TT: SBP þ 2.9 mm Hg, P ¼ 0.026; DBP þ 1.7 mm Hg, P ¼ 0.056, analysis of covariance adjusted by age, BMI and country of origin), but not in women ( Table 1 ). The possible role of age in the association between À344C/T and blood pressure was assessed by dividing the population by the median of age (M ¼ 47 years; F ¼ 44 years). The association still remained statistically significant only in younger males (o47 years) (CC þ CT vs TT: SBP þ 4.4 mm Hg, P ¼ 0.002; DBP þ 2.1 mm Hg, P ¼ 0.033), whereas no blood pressure difference was observed in older men and in women, independently of age (Table 1) .
In the whole population, the prevalence of hypertension was 33.1% in men and 16.5% in women. Although in older men and in women the prevalence of hypertension did not differ between genotypes (men 447 years CC þ CT 42.8%, TT 42.6%; women o44 years CC þ CT 8.6%, TT 8.3%; women 444 years CC þ CT 24.1%, TT 26.8%), in men younger than 47 years, significantly higher prevalence of hypertension was observed in the carriers of the C allele (CC þ CT 26.0%, TT 16.2%; w 2 0.038). The relative risk of hypertension, adjusted for BMI and country of origin, associated with the C allele was 2.09 (95% CI from 1.13 to 3.87).
Data on the association between the À344C/T CYP11B2 polymorphism and blood pressure are discordant, with some case-control studies suggesting a positive association of the T allele with hypertension, some association with the C allele and others no association. 2 Interestingly, previous studies suggested that the effects of CYP11B2 À344C/T polymorphism on other cardiovascular phenotypes, such as left ventricular mass 11 and baroreflex sensitivity, 12 might be age-dependent, being more evident in younger rather than in older population samples. In a previous study on a male population, we observed that the À344C/T genotype affected the relationships of blood pressure with age to a statistically significant extent. 6 In particular, CC subjects exhibited a different regression line of diastolic pressure on age as compared with T carriers, suggesting a possible regulatory activity of this polymorphism on age-related blood pressure increase. More recently, Sarzani et al. 7 showed that in a young adult population, the CC homozygotes had significantly higher SBP values as compared to carriers of the T allele. This effect was evident in males but not in females.
Our findings confirmed, in a large sample of couples randomly recruited from general practice in three European countries, the regulatory role of the CYP11B2 locus on the age-blood pressure relationship. The analyses were performed separately in men and women and the particular protocol of the IMMIDIET study 9 carried out in cohabiting partners, reduced at the minimum the impact of environmental factors on sex-related differences, often observed in association studies. In this setting, indeed a gender-related difference of the effects of the À344C/T polymorphism on blood pressure was also apparent.
In summary, CC homozygosis characterized a subset of male population with blood pressure levels higher than that observed in age-matched carriers of the T allele, thus suggesting that the C allele represents a marker of early susceptibility to hypertension. 
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